Melinda Taschetta-Millane, Editorial Director
Melinda Taschetta-Millane, Editorial Director
Blog | Melinda Taschetta-Millane, Editorial Director | Breast Imaging | October 03, 2018

Increased Awareness Teamed With Advanced Technology Saves Lives

About 40,920 women in the U.S. are expected to die from breast cancer this year

According to BreastCancer.org, an estimated 266,120 new cases of invasive breast cancer are expected to be diagnosed in the U.S. in 2018, along with 63,960 new cases of in situ breast cancer. About 1 in 8 U.S. women — around 12.4 percent — will develop invasive breast cancer over the course of her lifetime. About 40,920 women in the U.S. are expected to die from breast cancer this year, although death rates have been decreasing since 1989, with women under 50 experiencing larger decreases. Undoubtedly the stressed importance of early detection, increased awareness of breast density, and both treatment and technology advancements have played a large role in this slow but steady decline.

Breast imaging technologies have evolved fairly rapidly over the past two decades to help physicians detect breast cancers at an earlier stage. Clinical studies have proven the effectiveness of newer technologies such as automated breast ultrasound (ABUS), digital breast tomosynthesis (DBT) and breast magnetic resonance imaging (MRI) in finding more cancers that traditional mammograms might miss, as well as interval cancers that develop between screenings.

While the benefits of these and other supplemental screening methods have been demonstrated, a multimodality approach is not necessarily the best one for every woman. “It’s not a one-size-fits-all, it never has been in a lot of ways,” said Karen Hou, M.D., diagnostic radiologist at Northwestern Medicine Central DuPage Hospital (CDH) in Winfield, Ill., in the itnTV video “Breast Imaging and Risk Assessment at Northwestern Medicine Central DuPage.” To ensure that every woman gets the appropriate level of care she deserves, Hou and her colleagues at the CDH Breast Health Center opened the CDH High-Risk Breast Clinic in 2017.

In the video, Hou discusses ways to best implement the various breast screening technologies to serve your patient base. “You have to look at how you want it to fit your workflow, and make a decision on what you are going to use as a screening tool and what you are going to use to make a diagnostic decision. You want to be applying the technology in the most appropriate way so that patients will benefit the most,” she stated. “What we’ve done is try to use some kind of logic of what is accessible for people and what we could do to best serve them. It’s not a one-size-fits-all, it never has been in a lot of ways. It’s a lot of personalized customization of what is best for each individual’s care.”

Northwestern Medicine’s high-risk program entails its team trying to identify the high-risk individuals based on family and personal risk factors. “There are individuals who should not just have a mammogram once a year or every other year, and there are certain individuals who really should have more intense screening, and most importantly education and counseling,” Hou explained. “We have a high-risk clinic where people can get assessed, and they can sit down with somebody to really just discuss their personal level of risk and what they should be doing — it’s lifestyle, it’s having an understanding of what the reality is. We have identified early cancers in individuals who have been screened and would have otherwise been unsuspected. Here, we wanted to make it an established part of our program that is easily accessible.”

You can watch the video featuring Hou at https://bit.ly/2xCd2eT. To read more about advanced breast imaging technologies in this issue, see “The Evolution of Digital Breast Tomosynthesis” on page 28, and “Practicing Patient-Centered Mammography” on page 30.

 

Augmented Content

We continue our enhanced coverage of the industry through Blippar content. It’s an innovative way for you to view expanded content in several of our features in each issue. This issue, our augmented print campaign begins on page 17, where you can watch the VIDEO “Examples of Artificial Intelligence in Medical Imaging Diagnostics.” For additional breast imaging information, watch the VIDEO roundtable discussion, “Stereotactic Breast Biopsy Procedures: A Roundtable Discussion With the Cleveland Clinic.” And for more information on women’s health issues and breast density, watch the VIDEOS: “Breast Imaging and Risk Assessment at Northwestern Medicine Central DuPage,” “The Impact of Breast Density Technology and Legislation” and “Developments in Breast Density Legislation and Screening Guidelines.”

Related Content

Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress

Getty Images

News | Breast Imaging | July 09, 2020
July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metast
Hologic, Inc. announced he U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system.
News | Breast Imaging | July 08, 2020
July 8, 2020 — Hologic, Inc. announced he U.S.
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane
VolparaEnterprise data analysis shows mammography screening volumes are quickly increasing
News | Mammography | June 09, 2020
June 9, 2020 — More than 75 percent of hospitals and imaging centers that perform mammography across the United State
Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020
June 2, 2020 — Lunit announced that its artificia...
AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the xy and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.

News | Breast Imaging | May 26, 2020
May 26, 2020 — Breast cancer is the most common cancer in women.
Phone call and linkage-to-care-based intervention increases mammography uptake among primary care patients at an urban safety-net hospital

Getty Images

News | Mammography | May 22, 2020
May 22, 2020 — Telephone outreach coupled with scheduling assistance significantly increased...
The Breast Imaging and Reporting System (BI-RADS) was established by the American College of Radiology to help classify findings on mammography. Findings are classified based on the risk of breast cancer, with a BI-RADS 2 lesion being benign, or not cancerous, and BI-RADS 6 representing a lesion that is biopsy-proven to be malignant.

Getty Images

News | Breast Imaging | May 19, 2020
May 19, 2020 — Women with mammographically detected breast lesions that are probably benign should have follow-up sur